Sign In to Follow Application
View All Documents & Correspondence

A Composition Comprising Coumestrol, And Carnosic Acid And Uses Thereof

Abstract: The present disclosure relates to a composition comprising coumestrol, and carnosic acid which at particular weight ratios exhibits enhanced pain or inflammation inhibition. This composition finds potential application in formulations which can inhibit pain or inflammation.

Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence

Patent Information

Application #
Filing Date
12 May 2016
Publication Number
46/2017
Publication Type
INA
Invention Field
CHEMICAL
Status
Email
lsmds@lakshmisri.com
Parent Application

Applicants

ITC LIMITED
ITC LIFE SCIENCES & TECHNOLOGY CENTRE #3. 1ST MAIN, PEENYA INDUSTRIAL AREA, PHASE-1, BANGALORE 560 058.

Inventors

1. DSOUZA, Avin
ITC LIFE SCIENCES & TECHNOLOGY CENTRE #3. 1ST MAIN, PEENYA INDUSTRIAL AREA, PHASE-1, BANGALORE-560 058, INDIA.
2. NARAYANAPERUMAL, Jeyaparthasarathy
ITC LIFE SCIENCES & TECHNOLOGY CENTRE #3. 1ST MAIN, PEENYA INDUSTRIAL AREA, PHASE-1, BANGALORE 560 058.
3. GOPAL, Ganesh
ITC LIFE SCIENCES & TECHNOLOGY CENTRE #3. 1ST MAIN, PEENYA INDUSTRIAL AREA, PHASE-1, BANGALORE 560 058.

Specification

Claims:1. A composition comprising:
a. coumestrol; and
b. carnosic acid,
wherein coumestrol to carnosic acid w/w ratio in said composition is in the range of 1:0.1 to 1:1.22.
2. The composition as claimed in claim 1, wherein coumestrol weight percentage in said composition is in the range of 0.00045% to 0.0009%, and carnosic acid weight percentage in said composition is in the range of 0.00009% to 0.00055%.
3. The composition as claimed in claim 1, wherein coumestrol to carnosic acid w/w ratio in said composition is in the range of 1:0.25 to 1:1.
4. The composition as claimed in claim 3, wherein coumestrol weight percentage in said composition is in the range of 0.0005% to 0.0008%, and carnosic acid weight percentage in said composition is in the range of 0.0002% to 0.0005%.
5. The composition as claimed in claim 3, wherein coumestrol to carnosic acid w/w ratio in said composition is 1:0.25.
6. The composition as claimed in claim 5, wherein coumestrol weight percentage in said composition is 0.0008%, and carnosic acid weight percentage in said composition is 0.0002%.
7. The composition as claimed in claim 3, wherein coumestrol to carnosic acid w/w ratio in said composition is 1:0.66.
8. The composition as claimed in claim 7, wherein coumestrol weight percentage in said composition is 0.0004%, and carnosic acid weight percentage in said composition is 0.0006 %.
9. The composition as claimed in claim 3, wherein coumestrol to carnosic acid w/w ratio in said composition is 1:1.
10. The composition as claimed in claim 9, wherein coumestrol weight percentage in said composition is 0.0005%, and carnosic acid weight percentage in said composition is 0.0005%.
11. The composition as claimed in any of the claims 1-10, further comprising carriers, diluents, and excipients.
12. A method of preparing a composition as claimed in any of the claims 1-11.
13. A method for inhibiting pain or inflammation, said method comprising:
a. obtaining a composition as claimed in any of the claims 1-11; and
b. contacting said composition with a site of pain or inflammation,
wherein said method inhibits pain or inflammation.
, Description:As Attached

Documents

Application Documents

# Name Date
1 Form 5 [12-05-2016(online)].pdf 2016-05-12
2 Form 3 [12-05-2016(online)].pdf 2016-05-12
3 Drawing [12-05-2016(online)].pdf 2016-05-12
4 Description(Complete) [12-05-2016(online)].pdf 2016-05-12
5 Other Patent Document [10-08-2016(online)].pdf 2016-08-10
6 Form 26 [10-08-2016(online)].pdf 2016-08-10
7 201641016668-Power of Attorney-120816.pdf 2016-09-01
8 201641016668-Form 1-120816.pdf 2016-09-01
9 201641016668-Correspondence-F1-PA-120816.pdf 2016-09-01